SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001663577-24-000253
Filing Date
2024-09-12
Accepted
2024-09-12 16:52:18
Documents
15
Period of Report
2024-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K abti8k091224.htm   iXBRL 8-K 27407
5 CONVERTIBLE PROMISSORY NOTE, DATED AUGUST 30, 2024 ex4_1.htm EX-4.1 136846
6 GRAPHIC image_001.gif GRAPHIC 73
  Complete submission text file 0001663577-24-000253.txt   368532

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abti-20240830.xsd EX-101.SCH 3036
3 XBRL LABEL FILE abti-20240830_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abti-20240830_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT abti8k091224_htm.xml XML 3232
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

IRS No.: 821317032 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-156091 | Film No.: 241295536
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)